Sneddon's syndrome is usually characterized by the association of an ischemic cerebrovascular disease and a widespread livedo reticularis. The incidence of Sneddon syndrome is 4/1000 000. We present 42-year-old woman with livedo reticularis, recurrence ischaemic cerebrovascular accidents, two repetitive miscarriages and positive anti-2GPi antibodies. Skin biopsy specimens reveal inflammatory changes of small-to medium-sized arteries and subendothelial proliferation and fibrosis. The diagnosis Sneddon syndrome is confirmed by skin biopsy, and MR evidence.
INTRODUCTION
Sneddon's syndrome is caracterized by livedo reticularis associated with cerebrovascular disease. The condition affects small to medium sized arteries of the dermis-subcutis border. The process begins as an endothelial inflammation followed by occlusion, fibrosis and atrophy of the vessels. Antiphospholipid antibodies were found in some patients with Sneddon's syndrome. The disorder has a slow and progressive clinical course. No effective drug theraphy is available.
CASE REPORT
We report a case of Sneddon's syndrome in a 42 year-old woman. She suffered from cerebrovascular accident presented by double vision and lost of consciousness 5 years previously. Because of that she has been treated in the Department of Neurology. In May 2007 a recurrence of her neurological complaints occurred, expressed by dizziness, vomiting, ataxic walking, numbness and muscular debility of the left lower extremity. From medical history she had myocardial infarction three years ago and two repetitive miscarriages. The patient has been suffering from high blood pressure and migraine for 10 years. She has been having persistent cutaneous lesions on the upper and lower extremities and trunk for the last 20 years.
At physical examination, a slight elevation in pressure levels (150 x 80mm Hg), III degree obesity and slight edema of the lower limbs were found. The neurological examination revealed ataxic walk. The immunohistohemical examination with CD 34 of two skin biopsies from the livedo lesions revealed endothelial proliferation and obliteration of the small and middle arteries ( Figures 5, 6 ). The diagnosis of Sneddon syndrome in our patient was made on the basis of anamnesis, clinical features, skin biopsy and MNR. Therapeutics was instituted with 100 mg aspirin (acetylsalicylic acid) once a day. The systemic arterial hypertension was controlled.
DISCUSSION
In 1965, Ian Sneddon was the first author to establish a relationship between livedo reticularis and vascular neurological manifestations in six patients, thereby describing the syndrome that today takes his name (6, 8 ).
Sneddon's syndrome is a rare clinical entity of unknown etiology characterized by the association of livedo reticularis and cerebrovascular lesions (6, 10, 12) . It can also affects other internal organs (kidneys, heart, eyes and peripheral nerves) and in many cases there is concomitant systemic arterial hypertension (8, 9, 10, 12) . It predominates among young women although the mean age group at the moment of diagnosis is in the fifth decade (8, 9, 12) . The disease has a slow and progressive clinical course that can lead to disability or death, due to neurological problems or associated complications (11, 12). There is no treatment that has been recognized as effective. Livedo reticularis is characterized by persistent lesions with a cyanotic coloration, which are not influenced by temperature. (8) They are distributed in the form of an irregular network appearing in general in the trunk (gluteal region and inferior part of the back) from where it extends towards the extremities (along the thighs and dorsal surface of the arms). Livedo usually precedes the onset of the neurological picture, sometimes for several decades and can intensify in the acute phase of a neurological complication (8, 12) . The neurological picture as described by Sneddon consists of hemiplegia, aphasia, epilepsy, hemianopsia and hemianesthesia (5, 10). Since then, several other manifestations have been reported: migraine symptoms episodes of transitory cerebral ischemia, paresthesia, convulsions, vertigos, visual symptoms -scintillant scotomata, double vision (8, 12) . Manifestations related to the cardiovascular system include mild systemic arterial hypertension (occurring in 60 to 80% of the cases and considered by some authors to be part of the syndrome. There is no specific biological marker for Sneddon's syndrome. Routine laboratory exams are usually normal (8, 10) . Immunological studies are generally negative. Anti-DNA, anti-SSA, anti-SSB, anti-Sm and anti-RNP antibodies are never found (8) . Rheumatoid factor is also negative. However, occasionally the presence of antinuclear antibodies, cryoglobulins, antiphospholipid antibodies, anticardiolipin, lupus anticoagulant or anti-â2GPI antibodies can be detected (1, 6, 8, 9) . Imaging of the central nervous system can be made by CT or MNR (2, 8,12 ). CT and MNR are techniques with equal effectiveness in the detection of major and medium sized infarcts. However, MNR is more sensitive for the precocious detection of encephalic lesions and frequently reveals more extensive and numerous lesions than would be possible to see by CT (12) .
In the case reported here, anti-â2GPI antibody were positive (+). CT and MNR showed the presence of ischemic cerebral lesions. Histopathological study revealed that the disease affects small and medium arteries, located in the profound dermis and superior band of the subcutaneous cellular tissue (7) . No involvement of other organs was detected.
The etiology of the Sneddon's syndrome is unknown however, some associated factors that may participate in its etiopathogenesis or even aggravate its clinical course have been reported in the literature (6, 12) . There is evidence that female sex hormones could play a role. Systemic arterial hypertension is correlated to the progression of the damage to the central nervous system (8, 9) . The participation of antiphospholipid antibodies is also controversial (1, 3, 4) since there are reports of cases in which these antibodies were detected (1, 4, 6, 9) as well as others in which they were not (5, 12) . Thus, the relationship between Sneddon's syndrome and the Antiphospholipid antibody syndrome is not yet well established (1, 3, 6, 9) . It is also necessary to consider that classic manifestations of the latter, such as recurrent thrombosis of the veins or major arteries, thrombocytopenia and a history of spontaneous abortions, have not been reported in Sneddon's syndrome (8, 9, 12 ). Sneddon 's syndrome is not a homogeneous disease entity. Patients should be classified as "primary Sneddon's syndrome" if no aetiologic factor can be detected (4). On clinical grounds this form differs from several varieties of "Secondary Sneddon's syndrome" which occure mainly as part of an autoimmune disorder. When Sneddon's syndrome is associated with positive anticardiolipin antibodies it could be regarded as Antiphospholypid syndrome and fall into this category of nosological entity (4).
CONCLUSION:
We report a case of Sneddon's Syndrome, associated with an Antiphospholipid syndrome, presented by livedo reticularis, cerebrovascular disease, high blood pressure, migraine, two miscarriages and positive (+)anti-â2GPI antibody. In the reported case the livedo reticularis precedes the onset of the neurological picture for several decades. 
